MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Free Cash flow
-84,922
-117,425
-69,411
-76,928
Return on Equity
-14.762
-15.703
-14.26
-13.493
Net Profit Margin
-1,402.585
-647.947
-415.971
-732.746
Debt to Asset Ratio
15.103
18.166
20.274
19.114
Cash Ratio
133.676
176.201
149.652
206.334
Quick Ratio
664.843
610.176
507.981
620.896
Current Ratio
664.843
610.176
507.981
620.896

Time Plot

Show the time plot by selecting a row from the table.

Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics, Inc. (NTLA)